About Litmus Pharmaceuticals Private Limited
Data last updated:
Litmus Pharmaceuticals Private Limited is a private limited company based in Avadhpur, Haryana, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 01 October 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51101HR2014PTC053538. Its GSTIN is 06AACCL7551N1Z4 (Haryana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Santosh Devi and Bimla Devi Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 137 Anand Garden Near Railway Station, Avadhpur, Haryana, India – 122006.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.51 Lakh, a decline of 83% compared to the previous year. For the same year it recorded a net profit of ₹123 (net margin 0%) and EBITDA of ₹11,000 (EBITDA margin 3.1%). Revenue has declined at a compounded annual rate (CAGR) of 47% over three years and 37% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website litmuspharma.com.
Company details
Contact details
Litmus Pharmaceuticals Private Limited's registered office is in Avadhpur, Haryana. Its website is litmuspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address137 Anand Garden Near Railway Station, Avadhpur, Haryana, India – 122006
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Litmus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Litmus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Litmus Pharmaceuticals Private Limited, buy the company report.
Financials of Litmus Pharmaceuticals Private Limited
FY 2024 filings availableLitmus Pharmaceuticals Private Limited reported revenue of ₹3.51 Lakh (down 83% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 37% over five years, including a 83% fall in the latest year. EBITDA rose 570% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹123 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Litmus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Litmus Pharmaceuticals Private Limited
Litmus Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Devi | Director | 01 Oct 2014 | 12 Years 0 Months | Current |
| Bimla Devi Tiwari | Additional Director | 22 Jan 2016 | 10 Years 9 Months | Current |
Peer comparison
Litmus Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shubhecha Pharmaceuticals Private Limited | ₹3.54 Lakh (FY 2023) | 1084.0% | Lucknow, Uttar Pradesh, India | |||
| Medanta Pharmaceuticals Private Limited | ₹3.54 Lakh (FY 2022) | -58.0% | Ahmedabad, Gujarat, India | |||
| Cress Pharmaceuticals Private Limited | ₹3.54 Lakh (FY 2024) | -45.0% | Hyderabad, Telangana, India | |||
| Bio Oasis Pharmaceuticals Private Limited | ₹3.54 Lakh (FY 2025) | -18.0% | Khanpur, Deoli, Delhi, India | |||
| Litmus Pharmaceuticals Private Limitedthis company | ₹3.51 Lakh (FY 2024) | ₹123 | 0% | -83.0% | Avadhpur, Haryana, India | |
| Dryen Pharmaceuticals Private Limited | ₹3.48 Lakh (FY 2021) | -76.0% | Surat, Gujarat, India |
To see the full peer comparison of Litmus Pharmaceuticals Private Limited, buy the company report.
Auditor
Litmus Pharmaceuticals Private Limited is audited by RITA RANI & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RITA RANI & ASSOCIATES | FY 2017 | 536026 |
Shareholding
The shareholding of Litmus Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Litmus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Litmus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Litmus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Litmus Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AACCL7551N1Z4 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Litmus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Litmus Pharmaceuticals Private Limited has 4 board changes on record since 2014: 3 appointments and 1 cessation. The latest: Ashok Tiwari ceased to be Director on 22 Jan 2016.
Frequently asked questions
Litmus Pharmaceuticals is an active private limited company based in Avadhpur, Haryana, India. The company works in other wholesale, within the trading industry. It was incorporated on 01 October 2014 (12+ years old) and is registered under CIN U51101HR2014PTC053538.
Litmus Pharmaceuticals has 2 current directors:
- Santosh Devi - Director
- Bimla Devi Tiwari - Additional Director
The latest financial statements of Litmus Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Litmus Pharmaceuticals is 06AACCL7551N1Z4, registered in Haryana.
The CIN (Corporate Identification Number) of Litmus Pharmaceuticals is U51101HR2014PTC053538. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Litmus Pharmaceuticals was incorporated on 01 October 2014, making it 12+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Litmus Pharmaceuticals by revenue are Shubhecha Pharmaceuticals Private Limited, Medanta Pharmaceuticals Private Limited, Cress Pharmaceuticals Private Limited, Bio Oasis Pharmaceuticals Private Limited, Dryen Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ashok Tiwari ceased to be Director on 22 Jan 2016. Bimla Devi Tiwari was appointed as Additional Director on 22 Jan 2016. Ashok Tiwari was appointed as Director on 01 Oct 2014. Litmus Pharmaceuticals has 4 board changes on record in total.
Litmus Pharmaceuticals can be reached through the website litmuspharma.com. Its registered office is in Avadhpur, Haryana, India.
The registered office of Litmus Pharmaceuticals is at 137 Anand Garden Near Railway Station, Avadhpur, Haryana, India – 122006.
Litmus Pharmaceuticals operates in the trading industry, in the other wholesale segment.